Perspective Therapeutics, Inc. announced that it has certain Investment Agreement with new investor Lantheus Alpha Therapy, LLC to issue 56,342,355 common shares at an issue price of $0.589254 for the gross proceeds of $33,199,958.05317 on January 8, 2024. The Investment Agreement also provides investor with certain pro rata participation rights to maintain its ownership position in the Company in the event that the Company makes any public or non-public offering of any equity or voting interests in the Company or any securities that are convertible or exchangeable into (or exercisable for) equity or voting interests in the Company, subject to certain exceptions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.96 USD | -5.08% |
|
+1.87% | +197.51% |
01/07 | Perspective Therapeutics, Inc.(NYSEAM:CATX) added to Russell Small Cap Comp Value Index | CI |
01/07 | Perspective Therapeutics, Inc.(NYSEAM:CATX) added to Russell Small Cap Completeness Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+197.51% | 850M | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- CATX Stock
- News Perspective Therapeutics, Inc.
- Perspective Therapeutics, Inc. announced that it expects to receive $33.199958 million in funding